Influence of Cigarette Smoking on Drug Metabolism in Man

References

• Conney A. H., Pantuck E. J., Hsiao K.-C., Kuntzman R., Alvares A. P., Kappas A. “Regulation of Drug Metabolism in Man by Environmental Chemicals and Diet”. Fed. Proc 1977; 36: 1647–1652
   PubMedGoogle Scholar
• Jick H. “Smoking and Clinical Drug Effects”. Med. Clin. North Am. 1974; 58: 1143–1149
   PubMed Web of Science ®Google Scholar
• Jusko W. J. “Role of Tobacco Smoking in Pharmacokinetics,”. J. Pharmacokinet. Biopharm 1978; 6, In Press
   Google Scholar
• Beckett A. H., Triggs E. J. “Enzyme Induction in Man Caused by Smoking”. Nature 1967; 216: 587
   PubMed Web of Science ®Google Scholar
• Wenzel D. C., Broadie L. L. “Stimulatory Effect of Nicotine on the Metabolism of Meprobamate”. Toxicol. Appl. Pharmacol 1966; 8: 455–459
   PubMed Web of Science ®Google Scholar
• Yamamoto I., Nagai K., Kimura H., Iwatsubo K. “Nicotine and Some Carcinogens in Special Reference to the Hepatic Drug-Metabolizing Enzymes”. Jpn. J. Pharmacol 1966; 16: 183–190
   PubMedGoogle Scholar
• Pantuck E. J., Kuntzman R., Conney A. H. “Decreased Concentration of Phenacetin in Plasma of Cigarette Smokers”. Science 1972; 175: 1248–1250
   PubMed Web of Science ®Google Scholar
• Pantuck E. J., Hsiao K.-C., Maggio A., Nakamura K., Kuntzman R., Conney A. H. “Effect of Cigarette Smoking on Phenacetin Metabolism”. Clin. Pharmacol. Ther 1973; 15: 9–17
   Web of Science ®Google Scholar
• Gibaldi M., Perrier D. Pharmacokinetics. Dekker, New York 1975; 243–250
   Google Scholar
• Welch R. M., Cavallito J., Loh A. “Effect of Exposure to Cigarette Smoke on the Metabolism of Benzo(a)pyrene and Acetophenetidin by Lung and Intestine of Rats”. Toxicol. Appl. Pharmacol 1972; 23: 749–758
   PubMed Web of Science ®Google Scholar
• Pantuck E. J., Hsiao K.-C., Kaplan S. A., Kuntzman R., Conney A. H. “Effects of Enzyme Induction on Intestinal Phenacetin Metabolism in the Rat”. J. Pharmacol. Exp. Ther 1974; 191: 45–52
   PubMed Web of Science ®Google Scholar
• Vestal R. E., Norris A. H., Tobin J. D., Cohen B. H., Shock N. W., Andres R. “Antipyrine Metabolism in Man: Influence of Age, Alcohol, Caffeine, and Smoking”. Clin. Pharmacol. Ther 1975; 18: 425–432
   PubMed Web of Science ®Google Scholar
• Hart P., Farrell G. C., Cooksley W. G. E., Powell L. W. “Enhanced Drug Metabolism in Cigarette Smokers”. Br. Med. J. 1976; 2: 147–149
   PubMed Web of Science ®Google Scholar
• Klutz U., Avant G. R., Hoyumpa A., Schenker S., Wilkinson G. R. “The Effects of Age and Liver Disease on the Disposition and Elimination of Diazepam in Adult Man”. J. Clin. Invest 1975; 55: 347–359
   PubMed Web of Science ®Google Scholar
• Rose J. Q., Barron S. A., Jusko W. J. “Phenytoin Disposition in Smokers and Nonsmokers”. Int. J. Clin. Pharmacol 1978; 16: 547–550
   Google Scholar
• Yacobi A., Udall J. A., Levy G. “Serum Protein Binding as a Determinant of Warfarin Body Clearance and Anticoagulant Effect”. Clin. Pharmacol. Ther 1976; 19: 552–558
   PubMed Web of Science ®Google Scholar
• Mather L. E., Tucker G. T., Pflug A. E., Lindop M. J., Wilkerson C. “Meperidine Kinetics in Man, Intravenous Injection in Surgical Patients and Volunteers”. Clin. Pharmacol. Ther 1975; 1/7: 21–30
   Google Scholar
• Vestal R. E., McGuire E. A., Tobin J. D., Andres R., Norris A. H., Mezey E. “Aging and Ethanol Metabolism”. Clin. Pharmacol. Ther 1977; 21: 343–354
   PubMed Web of Science ®Google Scholar
• Norman T. R., Burrows G. D., Maguire K. P., Rubinstein G., Scoggins B. A., Davies B. “Cigarette Smoking and Plasma Nortriptyline Levels”. Clin. Pharmacol. Ther 1977; 21: 453–456
   PubMed Web of Science ®Google Scholar
• Jenne J., Nagasawa H., McHugh R., MacDonald F., Wyse E. “Decreased Theophylline Half-Life in Cigarette Smokers”. Life Sci 1975; 17: 195–198
   PubMed Web of Science ®Google Scholar
• Hunt S. N., Jusko W. J., Yurchak A. M. “Effect of Smoking on Theophylline Disposition”. Clin. Pharmacol. Ther 1976; 19: 546–551
   PubMed Web of Science ®Google Scholar
• Powell J. R., Thiereelin J.-F., Vozeh S., Sansom L., Riegelman S. “The Influence of Cigarette Smoking and Sex on Theophylline Disposition”. Am. Rev. Respir. Dis. 1977; 116: 17–24
   PubMed Web of Science ®Google Scholar
• Perel J. M., Hurvic M. J., Kanzler M. B. “Pharmacodynamics of Imipramine in Depressed Patients”. Psycho-pharmacol. Bull 1975; 11: 16–18
   PubMedGoogle Scholar
• Vaughan D. P., Beckett A. H., Robbie D. S. “The Influence of Smoking on the Inter-subject Variation in Pentazocine Elimination”. Br. J. Clin. Pharmacol 1976; 3: 279–283
   PubMed Web of Science ®Google Scholar
• Bridbord K., Finklea J. F., Wagoner J. K., Moran J. B., Caplan P. “Human Exposure to Polynuclear Aromatic Hydrocarbons”. Carcinogenesis, Vol. 1, Polynuclear Aromatic Hydrocarbons: Chemistry, Metabolism, and Car-cinogenesis, R. I. Freudenthal, P. W. Jones. Raven Press, New York 1976; 319–324
   Google Scholar
• Conney A. H. “Pharmacologic Implications of Microsomal Enzyme Induction”. Pharmacol. Rev. 1967; 19: 317–366
   PubMed Web of Science ®Google Scholar
• Gelboin H. V. “Mechanisms of Induction of Drug Metabolism Enzymes”. Handbook of Experimental Pharmacology, Vol. 28, Concepts in Biochemical Pharmacology, Part 2, B. B. Brodie, J. R. Gillette, H. S. Ackerman. Springer, Berlin 1971; 431–451
   Google Scholar
• Lohmann S. M., Miech R. P. “Theophylline Metabolism by the Rat Liver Microsomal System”. J. Pharmacol. Exp. Ther 1976; 196: 213–225
   PubMed Web of Science ®Google Scholar
• Piafsky K. M., Sitar D. S., Ogilvie R. I. “Effect of Phenobarbital on the Disposition of Intravenous Theophylline”. Clin. Pharmacol. Ther 1977; 22: 336–339
   PubMed Web of Science ®Google Scholar
• Koup J. R., Schentag J. J., Vance J. W., Kuritzky P. M., Pyszczynski D. R., Jusko W. J. “System for Clinical Pharmacokinetic Monitoring of Theophylline Therapy”. Am. J. Hosp. Pharm 1976; 33: 949–956
   PubMedGoogle Scholar
• Jusko W. J., Schentag J. J., Koup J. R. “Surveillance of Factors Affecting Theophylline Clearances: Age, Tobacco, Marihuana, Cirrhosis, Congestive Heart Failure, Obesity, Oral Contraceptives, Benzodiazepines, Barbiturates and Ethanol”. J. Pharm. Sci., In Press
   Web of Science ®Google Scholar
• Sonquist J. A., Morgan J. N. 1964, The Detection of Interaction Effects, Monograph No. 35, Survey Research Center, Institute for Social Research, The University of Michigan, as Program “NYBAID” by the Computing Center of the State University of New York
   Google Scholar
• Loughan P. M., Sitar D. S., Ogilvie R. I., Eisen A., Fox Z., Neims A. H. “Pharmacokinetic Analysis of the Disposition of Intravenous Theophylline in Young Children”. J. Pediatr 1976; 88: 874–879
   PubMed Web of Science ®Google Scholar
• Jusko W. J., Schentag J. J., Clark J. H., Gardner M., Yurchak A. M. “Enhanced Biotransformation of Theophylline in Marihuana and Tobacco Smokers”. Clin. Pharmacol. Ther 1978; 24: 406–410
   Web of Science ®Google Scholar
• Marcotte J., Skelton F. S., Cote M. G., Witschi H. “Induction of Aryl Hydrocarbon Hydroxylase in Rat Lung by Marihuana Smoke”. Toxicol. Appl. Pharmacol 1975; 33: 231–245
   PubMed Web of Science ®Google Scholar
• Paton W. D. “Pharmacology of Marihuana”. Ann. Rev. Pharmacol 1975; 15: 191–220
   PubMedGoogle Scholar
• Pfeifer H. J., Greenblatt D. J. “Clinical Toxicity of Theophylline in Relation to Cigarette Smoking, A Report from the Boston Collaborative Drug Surveillance Program”. Chest 1978; 73: 455–459
   PubMed Web of Science ®Google Scholar